Vertex Planning Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Sell
6,785
-30
-0.4% -$8.3K 0.22% 52
2026
Q1
$2.01M Buy
6,815
+34
+0.5% +$10.1K 0.39% 44
2025
Q4
$1.85M Sell
6,781
-183
-3% -$49.7K 0.43% 39
2025
Q3
$1.88M Buy
6,964
+7
+0.1% +$1.91K 0.36% 50
2025
Q2
$1.92M Buy
6,957
+16
+0.2% +$4.35K 0.4% 49
2025
Q1
$1.84M Buy
6,941
+63
+0.9% +$15.5K 0.4% 44
2024
Q4
$1.6M Buy
+6,878
New +$1.58M 0.35% 47

Other funds holding CME

Vertex Planning Partners's CME Position: Q2 2026 in Review

Vertex Planning Partners reduced its CME Group (CME) stake by 0.44% in Q2 2026, selling an estimated $8.3K and leaving 6,785 shares worth $1.5M. The position accounts for 0.22% of the portfolio, ranked #52.

Vertex Planning Partners first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.01M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Vertex Planning Partners held 6,785 shares of CME Group worth $1.5M as of Q2 2026.
  • Vertex Planning Partners sold 30 CME Group shares in Q2 2026, an estimated $8.3K.
  • CME Group made up 0.22% of Vertex Planning Partners's portfolio in Q2 2026, its #52 holding.
  • Vertex Planning Partners first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Vertex Planning Partners's CME Group position peaked at $2.01M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Vertex Planning Partners's 13F filing for Q2 2026, filed 14 Aug 2026.